Annual Working Capital
$34.66 M
-$3.67 M-9.58%
31 December 2023
Summary:
Forte Biosciences annual working capital is currently $34.66 million, with the most recent change of -$3.67 million (-9.58%) on 31 December 2023. During the last 3 years, it has fallen by -$22.98 million (-39.87%). FBRX annual working capital is now -39.87% below its all-time high of $57.64 million, reached on 31 December 2020.FBRX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$9.09 M
-$7.51 M-45.23%
30 September 2024
Summary:
Forte Biosciences quarterly working capital is currently $9.09 million, with the most recent change of -$7.51 million (-45.23%) on 30 September 2024. Over the past year, it has dropped by -$30.54 million (-77.07%). FBRX quarterly working capital is now -84.23% below its all-time high of $57.64 million, reached on 31 December 2020.FBRX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FBRX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.6% | -77.1% |
| 3 y3 years | -39.9% | -78.8% |
| 5 y5 years | - | - |
FBRX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -39.9% | at low | -78.8% | at low |
| 5 y | 5 years | -39.9% | at low | -84.2% | at low |
| alltime | all time | -39.9% | at low | -84.2% | at low |
Forte Biosciences Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $9.09 M(-45.2%) |
| June 2024 | - | $16.59 M(-41.1%) |
| Mar 2024 | - | $28.17 M(-18.7%) |
| Dec 2023 | $34.66 M(-9.6%) | $34.66 M(-12.5%) |
| Sept 2023 | - | $39.63 M(+62.1%) |
| June 2023 | - | $24.45 M(-24.8%) |
| Mar 2023 | - | $32.51 M(-15.2%) |
| Dec 2022 | $38.33 M | $38.33 M(-9.4%) |
| Sept 2022 | - | $42.30 M(+13.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $37.33 M(-4.7%) |
| Mar 2022 | - | $39.16 M(-3.9%) |
| Dec 2021 | $40.76 M(-29.3%) | $40.76 M(-4.8%) |
| Sept 2021 | - | $42.82 M(-12.4%) |
| June 2021 | - | $48.90 M(-8.6%) |
| Mar 2021 | - | $53.50 M(-7.2%) |
| Dec 2020 | $57.64 M | $57.64 M(+200.1%) |
| Sept 2020 | - | $19.21 M(-22.3%) |
| June 2020 | - | $24.71 M |
FAQ
- What is Forte Biosciences annual working capital?
- What is the all time high annual working capital for Forte Biosciences?
- What is Forte Biosciences annual working capital year-on-year change?
- What is Forte Biosciences quarterly working capital?
- What is the all time high quarterly working capital for Forte Biosciences?
- What is Forte Biosciences quarterly working capital year-on-year change?
What is Forte Biosciences annual working capital?
The current annual working capital of FBRX is $34.66 M
What is the all time high annual working capital for Forte Biosciences?
Forte Biosciences all-time high annual working capital is $57.64 M
What is Forte Biosciences annual working capital year-on-year change?
Over the past year, FBRX annual working capital has changed by -$3.67 M (-9.58%)
What is Forte Biosciences quarterly working capital?
The current quarterly working capital of FBRX is $9.09 M
What is the all time high quarterly working capital for Forte Biosciences?
Forte Biosciences all-time high quarterly working capital is $57.64 M
What is Forte Biosciences quarterly working capital year-on-year change?
Over the past year, FBRX quarterly working capital has changed by -$30.54 M (-77.07%)